Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer
Clinical trial NCT00096486 · COMPLETED
Trial details
- NCT number
- NCT00096486
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2010-07-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.